BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004;78:12308-19. [PMID: 15507618 DOI: 10.1128/JVI.78.22.12308-12319.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Tempera I, Lieberman PM. Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 2010;1799:236-45. [PMID: 19853673 DOI: 10.1016/j.bbagrm.2009.10.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
2 Tempera I, Wiedmer A, Dheekollu J, Lieberman PM. CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog 2010;6:e1001048. [PMID: 20730088 DOI: 10.1371/journal.ppat.1001048] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
3 Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, Showe L, Domsic J, Marmorstein R, Lieberman PM. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J Virol 2012;86:5752-62. [PMID: 22419807 DOI: 10.1128/JVI.07216-11] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
4 Nitzsche A, Steinhäusser C, Mücke K, Paulus C, Nevels M. Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin. J Virol 2012;86:9817-27. [PMID: 22761369 DOI: 10.1128/JVI.00581-12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
5 Hilton IB, Simon JM, Lieb JD, Davis IJ, Damania B, Dittmer DP. The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus. J Virol 2013;87:11831-42. [PMID: 23986576 DOI: 10.1128/JVI.01685-13] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
6 Day L, Chau CM, Nebozhyn M, Rennekamp AJ, Showe M, Lieberman PM. Chromatin profiling of Epstein-Barr virus latency control region. J Virol 2007;81:6389-401. [PMID: 17409162 DOI: 10.1128/JVI.02172-06] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
7 Dheekollu J, Chen HS, Kaye KM, Lieberman PM. Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability. J Virol 2013;87:3699-709. [PMID: 23325691 DOI: 10.1128/JVI.02211-12] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
8 Lieberman PM. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 2013;11:863-75. [PMID: 24192651 DOI: 10.1038/nrmicro3135] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
9 Iempridee T, Das S, Xu I, Mertz JE. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. J Virol 2011;85:7836-48. [PMID: 21593157 DOI: 10.1128/JVI.01197-10] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
10 Ott E, Norio P, Ritzi M, Schildkraut C, Schepers A. The dyad symmetry element of Epstein-Barr virus is a dominant but dispensable replication origin. PLoS One 2011;6:e18609. [PMID: 21603652 DOI: 10.1371/journal.pone.0018609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
11 Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer 2008;123:2105-12. [PMID: 18688856 DOI: 10.1002/ijc.23685] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
12 Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 2008;47:1655-66. [PMID: 18393372 DOI: 10.1002/hep.22231] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
13 Owen TJ, O'Neil JD, Dawson CW, Hu C, Chen X, Yao Y, Wood VH, Mitchell LE, White RJ, Young LS, Arrand JR. Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors. Mol Cancer 2010;9:241. [PMID: 20843307 DOI: 10.1186/1476-4598-9-241] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
14 Wang P, Day L, Dheekollu J, Lieberman PM. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J Virol 2005;79:13298-309. [PMID: 16227252 DOI: 10.1128/JVI.79.21.13298-13309.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
15 Senses KM, Gonen M, Barutcu AR, Kalaylioglu Z, Isbilen M, Konu O, Chen YT, Altorki NK, Gure AO. Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma. BMC Med Genet 2013;14:97. [PMID: 24063603 DOI: 10.1186/1471-2350-14-97] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 2006;80:5723-32. [PMID: 16731911 DOI: 10.1128/JVI.00025-06] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
17 Penkert RR, Kalejta RF. Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae 2011;2:3. [PMID: 21429246 DOI: 10.1186/2042-4280-2-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
18 Daigle D, Gradoville L, Tuck D, Schulz V, Wang'ondu R, Ye J, Gorres K, Miller G. Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. J Virol 2011;85:5628-43. [PMID: 21411522 DOI: 10.1128/JVI.02659-10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
19 Jha HC, Banerjee S, Robertson ES. The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens 2016;5:E18. [PMID: 26861404 DOI: 10.3390/pathogens5010018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
20 Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 2006;80:10700-11. [PMID: 16920819 DOI: 10.1128/JVI.01204-06] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
21 Lu F, Tempera I, Lee HT, Dewispelaere K, Lieberman PM. EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells. Virol J 2014;11:12. [PMID: 24460791 DOI: 10.1186/1743-422X-11-12] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
22 Tempera I, Lieberman PM. Epigenetic regulation of EBV persistence and oncogenesis. Semin Cancer Biol 2014;26:22-9. [PMID: 24468737 DOI: 10.1016/j.semcancer.2014.01.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
23 Dillon PJ, Gregory SM, Tamburro K, Sanders MK, Johnson GL, Raab-Traub N, Dittmer DP, Damania B. Tousled-like kinases modulate reactivation of gammaherpesviruses from latency. Cell Host Microbe 2013;13:204-14. [PMID: 23414760 DOI: 10.1016/j.chom.2012.12.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
24 Gerlitz G, Bustin M. Efficient cell migration requires global chromatin condensation. J Cell Sci 2010;123:2207-17. [PMID: 20530575 DOI: 10.1242/jcs.058271] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 6.7] [Reference Citation Analysis]
25 Dheekollu J, Lieberman PM. The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus. J Virol 2011;85:5853-63. [PMID: 21490103 DOI: 10.1128/JVI.02425-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
26 Huang J, Kent JR, Placek B, Whelan KA, Hollow CM, Zeng PY, Fraser NW, Berger SL. Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J Virol 2006;80:5740-6. [PMID: 16731913 DOI: 10.1128/JVI.00169-06] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
27 Alberter B, Vogel B, Lengenfelder D, Full F, Ensser A. Genome-wide histone acetylation profiling of Herpesvirus saimiri in human T cells upon induction with a histone deacetylase inhibitor. J Virol 2011;85:5456-64. [PMID: 21430050 DOI: 10.1128/JVI.00164-11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program. J Virol 2007;81:10092-100. [PMID: 17626071 DOI: 10.1128/JVI.00358-07] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
29 Chau CM, Deng Z, Kang H, Lieberman PM. Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp. J Virol 2008;82:3428-37. [PMID: 18216119 DOI: 10.1128/JVI.01412-07] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
30 Yoshioka M, Crum MM, Sample JT. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. J Virol 2008;82:1679-87. [PMID: 18077719 DOI: 10.1128/JVI.02142-07] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
31 Aras S, Singh G, Johnston K, Foster T, Aiyar A. Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathog 2009;5:e1000469. [PMID: 19521517 DOI: 10.1371/journal.ppat.1000469] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
32 Hughes DJ, Marendy EM, Dickerson CA, Yetming KD, Sample CE, Sample JT. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J Virol 2012;86:1034-45. [PMID: 22072770 DOI: 10.1128/JVI.05923-11] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
33 Lu F, Wikramasinghe P, Norseen J, Tsai K, Wang P, Showe L, Davuluri RV, Lieberman PM. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Virol J 2010;7:262. [PMID: 20929547 DOI: 10.1186/1743-422X-7-262] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
34 Lu F, Zankharia U, Vladimirova O, Yi Y, Collman RG, Lieberman PM. Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage. J Virol 2022;:e0016222. [PMID: 35319230 DOI: 10.1128/jvi.00162-22] [Reference Citation Analysis]
35 Stedman W, Kang H, Lin S, Kissil JL, Bartolomei MS, Lieberman PM. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J 2008;27:654-66. [PMID: 18219272 DOI: 10.1038/emboj.2008.1] [Cited by in Crossref: 266] [Cited by in F6Publishing: 267] [Article Influence: 19.0] [Reference Citation Analysis]
36 Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H, Kanda T, Tsurumi T. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells. J Virol 2012;86:4752-61. [PMID: 22357272 DOI: 10.1128/JVI.06768-11] [Cited by in Crossref: 66] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
37 Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas. Mediterr J Hematol Infect Dis 2009;1:e2009012. [PMID: 21416002 DOI: 10.4084/MJHID.2009.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
38 Kutluay SB, Triezenberg SJ. Role of chromatin during herpesvirus infections. Biochim Biophys Acta 2009;1790:456-66. [PMID: 19344747 DOI: 10.1016/j.bbagen.2009.03.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
39 Lu F, Chen HS, Kossenkov AV, DeWispeleare K, Won KJ, Lieberman PM. EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1. PLoS Pathog 2016;12:e1005339. [PMID: 26752713 DOI: 10.1371/journal.ppat.1005339] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
40 Lu F, Wiedmer A, Martin KA, Wickramasinghe PJMS, Kossenkov AV, Lieberman PM. Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus. J Virol 2017;91:e00804-17. [PMID: 28794029 DOI: 10.1128/JVI.00804-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
41 Dheekollu J, Wiedmer A, Sentana-Lledo D, Cassel J, Messick T, Lieberman PM. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. J Virol 2016;90:5353-67. [PMID: 27009953 DOI: 10.1128/JVI.00239-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Zhang Y, Jiang C, Trudeau SJ, Narita Y, Zhao B, Teng M, Guo R, Gewurz BE. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. mBio 2020;11:e01063-20. [PMID: 33109754 DOI: 10.1128/mBio.01063-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D. Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells. J Virol 2007;81:13242-7. [PMID: 17898065 DOI: 10.1128/JVI.01396-07] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
44 Dheekollu J, Wiedmer A, Ayyanathan K, Deakyne JS, Messick TE, Lieberman PM. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance. Cell 2021;184:643-654.e13. [PMID: 33482082 DOI: 10.1016/j.cell.2020.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]